← All Hillevax, INC filings

Hillevax, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

HLVX
Hillevax, INC
SCHEDULE: HilleVax Acquired, Tang Capital Exits Stake
HilleVax, Inc. completed its merger with XOMA Royalty Corporation, resulting in the cancellation of all HilleVax common stock and Tang Capital ceasing to be a beneficial owner.
HLVX
Hillevax, INC
SCHEDULE: Hillevax Goes Private After XOMA Tender Offer Completion
Hillevax, Inc. has completed its merger with XOMA Royalty Corporation, ceasing to be a publicly traded company.
HLVX
Hillevax, INC
SCHEDULE: HILLEVax Acquisition by XOMA Royalty Corp. Finalized
Frazier Life Sciences and related entities cease beneficial ownership of HILLEVax common stock following its acquisition by XOMA Royalty Corporation.
HLVX
Hillevax, INC
SCHEDULE 13D: Tang Capital Entities Disclose 9.8% Stake in HilleVax, Inc. for Investment Purposes
Tang Capital Management, Kevin Tang, and affiliated entities have filed a Schedule 13D, disclosing a beneficial ownership of 9.8% of HilleVax, Inc.'s common stock, acquired for investment purposes.